Slator 2019 Life Sciences Translation Report
Slator’s 2019 report on the clinical life sciences translation industry, analysis of the competitive landscape and actionable insights from major buyers of pharmaceutical translation.
*New* Slator Pro Guide: Scaling an LSP Key Account — Growing Small Clients into Key Accounts
drug development
Why Linguistic Validation Requires Not Just Conceptual but Cultural Equivalence
Adelina Lear of contract research organization ICON plc spoke at SlatorCon London on the role of language services and the linguistic validation workflow in clinical trials.
Your information will not be shared with third parties. No Spam.